These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 8749850

  • 1. Control of crystal forms of apoferritin by site-directed mutagenesis.
    Takeda S, Yoshimura H, Endo S, Takahashi T, Nagayama K.
    Proteins; 1995 Dec; 23(4):548-56. PubMed ID: 8749850
    [Abstract] [Full Text] [Related]

  • 2. Structural analysis of haemin demetallation by L-chain apoferritins.
    de Val N, Declercq JP, Lim CK, Crichton RR.
    J Inorg Biochem; 2012 Jul; 112():77-84. PubMed ID: 22561545
    [Abstract] [Full Text] [Related]

  • 3. EPR studies of recombinant horse L-chain apoferritin and its mutant (E 53,56,57,60 Q) with haemin.
    de Val N, Hagen WR, Crichton RR.
    Biometals; 2007 Feb; 20(1):21-6. PubMed ID: 16988881
    [Abstract] [Full Text] [Related]

  • 4. Evidence of new cadmium binding sites in recombinant horse L-chain ferritin by anomalous Fourier difference map calculation.
    Granier T, Comberton G, Gallois B, d'Estaintot BL, Dautant A, Crichton RR, Précigoux G.
    Proteins; 1998 Jun 01; 31(4):477-85. PubMed ID: 9626706
    [Abstract] [Full Text] [Related]

  • 5. Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis.
    Choi HK, Lee S, Zhang YP, McKinney BR, Wengler G, Rossmann MG, Kuhn RJ.
    J Mol Biol; 1996 Sep 20; 262(2):151-67. PubMed ID: 8831786
    [Abstract] [Full Text] [Related]

  • 6. Effect of N-terminal residues on the structural stability of recombinant horse L-chain apoferritin in an acidic environment.
    Yoshizawa K, Mishima Y, Park SY, Heddle JG, Tame JR, Iwahori K, Kobayashi M, Yamashita I.
    J Biochem; 2007 Dec 20; 142(6):707-13. PubMed ID: 17938140
    [Abstract] [Full Text] [Related]

  • 7. Fabrication of nickel and chromium nanoparticles using the protein cage of apoferritin.
    Okuda M, Iwahori K, Yamashita I, Yoshimura H.
    Biotechnol Bioeng; 2003 Oct 20; 84(2):187-94. PubMed ID: 12966575
    [Abstract] [Full Text] [Related]

  • 8. Two-dimensional crystals of apoferritin.
    Yoshimura H.
    Adv Biophys; 1997 Oct 20; 34():93-107. PubMed ID: 9204129
    [Abstract] [Full Text] [Related]

  • 9. The Cfr10I restriction enzyme is functional as a tetramer.
    Siksnys V, Skirgaila R, Sasnauskas G, Urbanke C, Cherny D, Grazulis S, Huber R.
    J Mol Biol; 1999 Sep 03; 291(5):1105-18. PubMed ID: 10518946
    [Abstract] [Full Text] [Related]

  • 10. Mutational analysis of the thermostable arginine repressor from Bacillus stearothermophilus: dissecting residues involved in DNA binding properties.
    Karaivanova IM, Weigel P, Takahashi M, Fort C, Versavaud A, Van Duyne G, Charlier D, Hallet JN, Glansdorff N, Sakanyan V.
    J Mol Biol; 1999 Aug 27; 291(4):843-55. PubMed ID: 10452892
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of Y34F mutant human mitochondrial manganese superoxide dismutase and the functional role of tyrosine 34.
    Guan Y, Hickey MJ, Borgstahl GE, Hallewell RA, Lepock JR, O'Connor D, Hsieh Y, Nick HS, Silverman DN, Tainer JA.
    Biochemistry; 1998 Apr 07; 37(14):4722-30. PubMed ID: 9537987
    [Abstract] [Full Text] [Related]

  • 12. Molecular-level thermodynamic and kinetic parameters for the self-assembly of apoferritin molecules into crystals.
    Yau ST, Petsev DN, Thomas BR, Vekilov PG.
    J Mol Biol; 2000 Nov 10; 303(5):667-78. PubMed ID: 11061967
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the structures of the cubic and tetragonal forms of horse-spleen apoferritin.
    Granier T, Gallois B, Dautant A, Langlois d'Estaintot B, Précigoux G.
    Acta Crystallogr D Biol Crystallogr; 1997 Sep 01; 53(Pt 5):580-7. PubMed ID: 15299889
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y, Urrutia M, Smith-Gill SJ, Mariuzza RA.
    Biochemistry; 2003 Jan 14; 42(1):11-22. PubMed ID: 12515535
    [Abstract] [Full Text] [Related]

  • 17. The 2.15 A crystal structure of a triple mutant plastocyanin from the cyanobacterium Synechocystis sp. PCC 6803.
    Romero A, De la Cerda B, Varela PF, Navarro JA, Hervás M, De la Rosa MA.
    J Mol Biol; 1998 Jan 16; 275(2):327-36. PubMed ID: 9466912
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The crystal structure of the monomeric human SOD mutant F50E/G51E/E133Q at atomic resolution. The enzyme mechanism revisited.
    Ferraroni M, Rypniewski W, Wilson KS, Viezzoli MS, Banci L, Bertini I, Mangani S.
    J Mol Biol; 1999 May 07; 288(3):413-26. PubMed ID: 10329151
    [Abstract] [Full Text] [Related]

  • 20. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D, Barros F, Pardo LA, de la Peña P.
    Biochemistry; 1997 Mar 18; 36(11):3308-18. PubMed ID: 9116009
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.